PharmaShots | Incisive News in 3 Shots

Subscribe Now

Aged 12 to < 24 Months

Vertex's Kalydeco (ivacaftor) Receives FDA's Expanded Label Approval for Cystic Fibrosis (CF) Aged 12 to < 24 Months

Vertex's Kalydeco (ivacaftor) Receives FDA's Expanded Label Approval for Cystic Fibrosis (CF) Aged 12 to < 24 Months

November 30, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us